Peer-reviewedCC BY-NC-ND 4.0JAMA Cardiology23 Sep 2026

Undiagnosed Chronic Kidney Disease, Outcomes, and Finerenone in Heart Failure

John W Ostrominski
Finnian R Mc Causland
Brian L Claggett
Akshay S Desai
Pardeep S Jhund
Alasdair Henderson
Carolyn S P Lam
Michele Senni
Sanjiv J Shah
Adriaan A Voors
Faiez Zannad
Bertram Pitt

7 more authors

Flaviana Amarante
Meike Brinker
Patrick Schloemer
Katja Rohwedder
John J V Mcmurray
Scott D Solomon
Muthiah Vaduganathan

Abstract

This secondary analysis of the FINEARTS-HF (Finerenone Trial to Investigate Efficacy and Safety Superior to Placebo in Patients With Heart Failure) randomized clinical trial investigates the prevalence of undiagnosed chronic kidney disease in high-risk individuals with heart failure and its association with cardiovascular outcomes.

Association between finerenone use and risk of new-onset heart failure in chronic kidney disease: a propensity-matched cohort study using the TriNetX network.
Jheng-Yan Wu, Keng-Wei Lee, Sheng-Chi Huang +2
BMC cardiovascular disorders1 Aug 2026Peer-reviewedCC BY-NC-NDFull textCardiovascular medicineEurope PMCPMC
Longitudinal kidney outcomes and safety after finerenone initiation in patients with non-diabetic chronic kidney disease: a single-center retrospective cohort study
Xuejuan Sun, Juan Pei, Xing Chen +6
Frontiers in medicine19 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMCPMCEurope PMC
Prevalence, Health Care Burden, and Longitudinal Outcomes of Chronic Obstructive Pulmonary Disease Among People With Heart Failure
Tauben Averbuch, Brandon Zagorski, Joan Carles Trullàs +2
CJC open10 Jul 2026Peer-reviewedCC BY-NC-NDFull textCardiovascular medicineEurope PMC
Efficacy and safety of finerenone in patients with chronic kidney disease: an individual participant data pooled analysis (INFINITY)
Brendon Lange Neuen, Hiddo J.L. Heerspink, Vlado Perkovic +21
The Lancet1 Jun 2026Peer-reviewedLicence not stated21 citedGeneral medicineOpenAlex
Clinical outcomes and safety of finerenone in patients with heart failure: a real-world observational study in China
Cuimei Zhao, Bing Sun, Huifeng Xu +3
Frontiers in Cardiovascular Medicine26 Oct 2026Peer-reviewedCC BY 4.0Full textCardiovascular medicineCrossrefDOAJ

Cite

BibTeX RIS

BibTeX

@article{ostrominski2026undiagnosed,
  title = {{Undiagnosed Chronic Kidney Disease, Outcomes, and Finerenone in Heart Failure}},
  author = {John W Ostrominski and Finnian R Mc Causland and Brian L Claggett and Akshay S Desai and Pardeep S Jhund and Alasdair Henderson and Carolyn S P Lam and Michele Senni and Sanjiv J Shah and Adriaan A Voors and Faiez Zannad and Bertram Pitt and Flaviana Amarante and Meike Brinker and Patrick Schloemer and Katja Rohwedder and John J V Mcmurray and Scott D Solomon and Muthiah Vaduganathan},
  journal = {JAMA Cardiology},
  year = {2026},
  month = sep,
  doi = {10.1001/jamacardio.2026.3507},
  url = {https://hal.univ-lorraine.fr/hal-05764721v1},
  note = {CC BY-NC-ND 4.0},
}

RIS

TY  - JOUR
TI  - Undiagnosed Chronic Kidney Disease, Outcomes, and Finerenone in Heart Failure
AU  - John W Ostrominski
AU  - Finnian R Mc Causland
AU  - Brian L Claggett
AU  - Akshay S Desai
AU  - Pardeep S Jhund
AU  - Alasdair Henderson
AU  - Carolyn S P Lam
AU  - Michele Senni
AU  - Sanjiv J Shah
AU  - Adriaan A Voors
AU  - Faiez Zannad
AU  - Bertram Pitt
AU  - Flaviana Amarante
AU  - Meike Brinker
AU  - Patrick Schloemer
AU  - Katja Rohwedder
AU  - John J V Mcmurray
AU  - Scott D Solomon
AU  - Muthiah Vaduganathan
PY  - 2026
DA  - 2026/09/23
JO  - JAMA Cardiology
DO  - 10.1001/jamacardio.2026.3507
UR  - https://hal.univ-lorraine.fr/hal-05764721v1
AB  - This secondary analysis of the FINEARTS-HF (Finerenone Trial to Investigate Efficacy and Safety Superior to Placebo in Patients With Heart Failure) randomized clinical trial investigates the prevalence of undiagnosed chronic kidney disease in high-risk individuals with heart failure and its association with cardiovascular outcomes.
SN  - 2380-6583
SN  - 2380-6591
ER  -

Abstract

Related

Cite